Results 51 to 60 of about 3,000,774 (406)

Neuroendocrine Tumor of the Gallbladder [PDF]

Polish Journal of Radiology, 2015
BACKGROUND: The primary neuroendocrine tumors of the gallbladder are very rare, representing 0.2% of all neuroendocrine tumors. The definite diagnosis is incidental in most cases. CASE REPORT: A 60-year-old male patient presented with a one-month history of epigastric pain and jaundice, itching, flushing, cough and wheezing. Ultrasound demonstrated the
Monier, Ahmed, Saloum, Nehal, Szmigielski, Wojciech, Alrashid, Amal, Napaki, Sarbar M. E.   +4 more
openaire   +3 more sources

The prognostic analysis of different metastatic patterns in pancreatic neuroendocrine tumors patients

Medicine, 2019
Objective: To evaluate the prognostic value of pancreatic neuroendocrine tumors (pNETs) with different metastatic patterns. Methods: Data of pNETs cases were extracted from the Surveillance, Epidemiology, and End Result (SEER) database.
Sumei Wang, Jiandong Zhang, Shuye Liu, Jinjuan Zhang   +3 more
semanticscholar   +1 more source

Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours [PDF]

, 2019
Pancreatic Neuroendocrine Neoplasms comprise a group of rare tumours with special biology, an often indolent behaviour and particular diagnostic and therapeutic requirements.
Almar E., Arveux P., Autelitano M., Baldi I., Bara S., Barchielli A., Benfatto L., Benhamou E., Bento M. J., Bielska-Lasota M., Blaszczyk J., Bordoni A., Botta L., Bouchardy C., Bouvier A. -M., Bouvier V., Brewster D. H., Calleja N., Candela P., Caplin M., Capocaccia R., Carulla M., Clough-Gorr K., Colonna M., Comber H., De Angelis R., de Lacerda G. F., de Munain A. L., Diaz Garcia J. M., Diba C. S., Dimitrova N., Dusek L., Engel J., Ess S. M., Falcini F., Falconi M., Ferretti S., Filiberti R. A., Fusai G. K., Fusco M., Galceran J., Gatta G., Gavin A., Gennaro V., Gentilini M., Giacomin A., Gozdz S., Grosclaude P., Guizard A. -V., Hackl M., Heidrich J., Henau K., Holleczek B., Huws D. W., Iannelli A., Johannesen T. B., Jonasson J. G., Kepska K., Knijn A., Konzelmann I., Kunkler I., Lapotre-Ledoux B., Larranaga N., Leinonen M., Luttmann S., Lykoudis P. M., Madeddu A., Magi M., Malila N., Mallone S., Mangone L., Marani E., Marcos-Gragera R., Maspero S., Maynadie M., Mazzoleni G., Michiara M., Miranda A., Molinie F., Monnereau A., Moreno-Iribas C., Mousavi M., Muffatti F., Navarro C., Nennecke A., Pannozzo F., Partelli S., Pierannunzio D., Piffer S., Pildava S., Primic-Zakelj M., Rachtan J., Rashbass J., Ricci P., Robaszkiewicz M., Rossi S., Rugge M., Salmeron D., Sanchez M. J., Santaquilani M., Sardo A. S., Schubert-Fritschle G., Schvartz C., Sekerija M., Sensi F., Serraino D., Smailyte G., Spagnoli G., Stabenow R., Stracci F., Tagliabue G., Tavilla A., Torrella-Ramos A., Trama A., Tretarre B., Troussard X., Tumino R., Usala M., Van Eycken E., Velten M., Visser O., Vitale F., Woronoff A. -S., Ziino A.   +123 more
core   +4 more sources

Blood Transcript Profiling for the Detection of Neuroendocrine Tumors: Results of a Large Independent Validation Study

Frontiers in Endocrinology, 2018
Background: Available neuroendocrine biomarkers are considered to have insufficient accuracy to discriminate patients with gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs) from healthy controls.
Mark J. C. van Treijen, Mark J. C. van Treijen, Catharina M. Korse, Catharina M. Korse, Rachel S. van Leeuwaarde, Rachel S. van Leeuwaarde, Lisette J. Saveur, Lisette J. Saveur, Menno R. Vriens, Menno R. Vriens, Wieke H. M. Verbeek, Wieke H. M. Verbeek, Margot E. T. Tesselaar, Margot E. T. Tesselaar, Gerlof D. Valk, Gerlof D. Valk   +15 more
doaj   +1 more source

Renal neuroendocrine tumors

Indian Journal of Urology, 2009
Neuroendocrine tumors (NETs) are uncommon tumors that exhibit a wide range of neuroendocrine differentiation and biological behavior. Primary NETs of the kidney, including carcinoid tumor, small cell carcinoma (SCC), and large cell neuroendocrine carcinoma (LCNEC) are exceedingly rare.The clinicopathologic features of renal NETs diagnosed at a single ...
Ming Zhou, Brian R. Lane, George Jour
openaire   +3 more sources

A nationwide, multi‐institutional collaborative retrospective study of colorectal neuroendocrine tumors in Japan

Annals of Gastroenterological Surgery, 2021
Aim Neuroendocrine tumors (NETs) are one of the subtypes of neuroendocrine neoplasms and are defined as epithelial neoplasms with predominant neuroendocrine differentiation.
Tatsuro Yamaguchi, Keiichi Takahashi, Kazutaka Yamada, Hiroyuki Bando, Hideo Baba, Masaaki Ito, Kimihiko Funahashi, Hideki Ueno, Shin Fujita, Seiji Hasegawa, Yoshiharu Sakai, Kenichi Sugihara   +11 more
doaj   +1 more source

Neuroendocrine tumors of the gallbladder (Review)

Oncology Letters, 2020
A gallbladder neuroendocrine neoplasm (GB-NEN) is a unique heterogeneous neoplasm, originating from neuroendocrine cells and able to secrete peptides as its neurotransmitter. Among all the neuroendocrine tumors (NETs), the GB-NEN prevalence is 0.5%, which accounts for ~2.1% of all gallbladder tumors.
Chunyuan Niu, Shupeng Wang, Qingchun Guan, Xuekang Ren, Bai Ji, Yahui Liu   +5 more
openaire   +4 more sources

ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors

Neuroendocrinology, 2016
ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine ...
M. Falconi, B. Eriksson, G. Kaltsas, D. Bartsch, J. Capdevila, M. Caplin, B. Kos-Kudła, D. Kwekkeboom, G. Rindi, G. Klöppel, N. Reed, R. Kianmanesh, R. Jensen   +12 more
semanticscholar   +1 more source

Fine needle aspiration cytology of hepatic metastases of neuroendocrine tumors: A 20‐year retrospective, single institutional study [PDF]

, 2017
Background Fine needle aspiration (FNA) is considered an excellent technique for documenting metastatic neuroendocrine tumors (NETs). This study aims to evaluate the accuracy of FNA in diagnosing metastatic NETs to the liver and determining the grade ...
Cramer, Harvey, Saeed, Omer A., Wang, Xiaoyan, Wu, Howard H.   +3 more
core   +1 more source

Treatment options for PNET liver metastases. a systematic review [PDF]

, 2018
Pancreatic neuroendocrine tumors (PNETs) are rare pancreatic neoplasms. About 40-80% of patients with PNET are metastatic at presentation, usually involving the liver (40-93%). Liver metastasis represents the most significant prognostic factor.
Aurello, Paolo, Crovetto, Anna, Debs, Tarek, Mangogna, Livia Maria, Moschetta, Giovanni, Nigri, Giuseppe, Persechino, Raffaello, Petrucciani, Niccolò, Ramacciato, Giovanni   +8 more
core   +1 more source